Payton Nyquvest is the founder and CEO of Numinus, a mental health company at the forefront of the psychedelic-assisted therapy movement. He's raised over $80 million for the startup, which currently offers psychedelic-assisted therapy, traditional talk therapy, and practitioner training--and conducts research trials. In this episode, Payton shares with Megan how psychedelics saved his life and the challenges of marketing and scaling while maintaining clinical ethics and integrity.
Podden och tillhörande omslagsbild på den här sidan tillhör Megan Bruneau. Innehållet i podden är skapat av Megan Bruneau och inte av, eller tillsammans med, Poddtoppen.
